TLDR PRP patients show varied symptoms and need more research to understand related conditions.
The study on Pityriasis Rubra Pilaris (PRP) aimed to characterize the disease features and associated medical diagnoses in patients. PRP is a rare disorder marked by hyperkeratotic follicular papules, scaling erythematous plaques, and palmoplantar keratoderma, with significant variability in clinical presentation. Not all patients progress to erythroderma, and some may develop seronegative arthritis. The prevalence of arthropathy, alopecia, anhidrosis, and other medical conditions in PRP patients was not well-documented, highlighting the need for further research to better understand these associations.
13 citations,
January 2019 in “Journal of the American Academy of Dermatology” Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.
January 2017 in “Springer eBooks” The document explains various skin conditions and their treatments.
9 citations,
November 2000 in “Journal of the American Academy of Dermatology” A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.
36 citations,
November 2000 in “Journal of the American Academy of Dermatology” A woman with dermatomyositis showed rare skin symptoms, was treated successfully, and her case suggests checking for cancer in similar patients.
2 citations,
January 2014 in “Springer eBooks” The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.
January 2018 in “Springer eBooks” PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.
